Ford is attempting to boost sales of its crucial F-150 pickup truck before the end of the third quarter by offering special financing to consumers with less-than-perfect credit ratings. The move includes offering consumers with subprime credit — those with a FICO score below 620 — lower interest rates offered to those with quality scores.

Medicus Pharma (NASDAQ:MDCX) announced that Stonegate Capital Partners has initiated coverage on the company. Stonegate analysts wrote that with the closing of its $8 million debenture financing, Medicus has cash of $9.7 million as of the second quarter of 2025, which extends the company's runway into 2026.

The iShares MSCI Brazil-Capped ETF is rated a "Buy," supported by strong recent momentum and compelling valuation metrics. EWZ offers exposure to large- and mid-cap Brazilian equities, with a focus on value sectors like Financials and Energy. The ETF trades at a low 9.2x P/E and a PEG ratio below one, with a high 5.13% dividend yield, making it attractive for investors.

LRCX surges 70% in six months, fueled by AI chip demand and strong earnings, but near-term risks cloud its outlook.

U.S.-listed shares of Lithium Americas surged more than 70% in premarket trading on Wednesday after a report said the Trump administration was seeking an equity stake of up to 10% in the miner, the latest sign of involvement in industries the government sees as critical to national security.

The Trade Desk's record-high JBPs and rapid adoption of Kokai and OpenPath highlight its expanding role in ad tech growth.

Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST) was a big mover last session on higher-than-average trading volume.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cytokinetics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept.

The chip maker's board authorizes a new $5 billion buyback program.

Despite the political noise coming out of the White House over efforts to lower drug prices, Amgen Inc.'s oncology franchise has continued to deliver strong performance since the start of 2025. So, AMGN's sales of Imdelltra, which is rapidly capturing the lung cancer therapeutics market, reached $134 million in Q2 2025, an impressive 1016.7% increase year-over-year. Also, thanks to the synergy effects from the acquisition of Horizon, as well as growing demand for Blincyto, AMGN's gross profit margin reached 70.9%, 9.5% higher than in Q2 2024.

Micron Technology, Inc. delivered record fiscal Q4 earnings, fueled by surging AI-driven demand for its high-bandwidth memory products in Data Centers. MU's revenue soared 46% year-over-year to $11.3B, with free cash flow up 149% Y/Y, reflecting explosive growth in its HBM segment. Revenue related to HBM, high-capacity DIMMs and LP server DRAM reached 10.0B in Q4'25, due to considerable demand strength for high-bandwidth memory solutions from hyperscalers.

INFU, CENX, RELY and GLDD boast strong net margins, rising earnings and bullish analyst ratings that signal upside.

TTD expands with Kokai and CTV gains, but MGNI's partnerships, AI tools, and stock surge make the ad-tech battle tighter.

Besides Wall Street's top-and-bottom-line estimates for Carnival (CCL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended August 2025.

Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate the expected performance of Progress Software (PRGS) for the quarter ended August 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Corning (GLW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Beyond analysts' top-and-bottom-line estimates for Jefferies (JEF), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended August 2025.

Get a deeper insight into the potential performance of Vail Resorts (MTN) for the quarter ended July 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.